Feb 20, 2026 Some researchers see dramatic appetite suppression within hours
So how do these benefits occur
44 There are ongoing studies evaluating the efficacy of orforglipron on weight loss and cardiovascular outcomes (clinical trial number NCT05803421
As tirzepatide was compared to controls, the hazard ratios for MACE-4 were 0.80 (95% confidence interval [CI], 0.571.11), cardiovascular death was 0.90 (95% CI, 0.501.61), and all-cause death was 0.80 (95% CI, 0.511.25) [2]
Septal glucagon-like peptide 1 receptor expression determines suppression of cocaine-induced behavior
Kidney Issues: Kidney problems, including acute kidney injury, have been reported in a small number of patients, particularly those with pre-existing kidney conditions